2Anthonisen NR, Manfreda J, Wan'en CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[ J]. Ann Intern Med, 1987,106 : 196 - 204.
3Sethi S. Bacterial infection and the pathogenesis of COPD [ J ]. Chest,2000,117:286S - 291S.
4Soler N, Ewig S, Tones A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease [ J ]. Eur Respir J, 1999,14 : 1015 - 1022.
5Seemungal T, HarperoOwen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseI J]. Am J Respir Crit Care Med ,2001,164 : 1618 - 1623.
6Beckham JD, Cadena A, Lin J, et al. Respiratory viral infections in patients with chronic, obstructive pulmonary disease [ J ]. J Infect, 2005,50:322 - 330.
7Krug RM, Aramini JM. Emerging antiviral targets for influenza A virus [ J ]. Trends Pharmacol Sci,2009,30 ( 6 ) :269 - 277.
8Sivaprakasam V, Collins TC, Aitken C,et al. Life-threatening human metapneumovirus infections, in West of Scotland [ J ]. J Clin Virol,2007 ,39 :234 - 237.
9Roger T,Bresser P,Snoek M,et al. Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus type 4-infected NCI- H292 cells[ J ]. Am J Physiol Lung Cell Mol Physiol,2004,287 : L1048 - L1055.
10Hacievliyagil SS, Gunen H, Mutlu LC, et al. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease [ J ]. Respir Med,2006,100 : 846 - 854.
